US$ 28.76
compound glp 1 news Digital pharmacy to offer weight-loss drug cheaper than Ozempic Managing Compounded GLP-1 Medications: A
Description
Recent research has also associated these diabetes drugs with decreased bone health since they can reduce bone mineral density and increase bone turnover, potentially increasing fracture risk

Glucagon-like peptide-1 receptor agonist prevented the progression of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis

I don't think it will be a fringe thing for long

For pharmaceutical companies, investors, healthcare providers, payers, and market research teams, the key question is no longer whether GLP-1 drugs will remain important
doi:10.1016/0167-0115(96)00135-8
